Mauna Kea Technologies : Mauna Kea et J&J passent à la vitesse supérieure
>Lancement d’une étude en pneumologie - Mauna Kea passe une étape importante aujourd’hui avec l’annonce du lancement d’une première étude chez l’homme combinant sa plateforme Cellvizio (endomicroscopie laser confocale par minisonde et par aiguille) avec le robot Monarch d’Auris Health (groupe Johnson & Johnson) pour le diagnostic des nodules pulmonaires. Il s’agit donc d’une matérialisation majeure du développement de la société dans le domaine de la pneumologie, le p...Mauna Kea Technologies is a global medical device company based in France. Co. is focused on innovations in the field of endomicroscopy (microscopic imaging during endoscopy procedures). Co. is predominately active in the advent of optical biopsy. Co. researches, develops and markets innovative tools to visualize and detect cellular abnormalities during endoscopic procedures. Co.'s flagship product, Cellvizio®, a probe-based Confocal Laser Endomicroscopy (pCLE) system, provides physicians and researchers high-resolution cellular views of tissue inside the body. Co. has marketing authorizations in Thailand, United Kingdom, U.S., Brazil, Chile, South Korea, Poland, Russia and Saudi Arabia.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.